MedPath

The effect of salbutamol nebulizer in the treatment of acute asthma attack

Phase 3
Conditions
Asthma attack of children.
Unspecified asthma
J45.90
Registration Number
IRCT20181102041527N1
Lead Sponsor
Shahid Beheshti University of Medical Sciences
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete
Sex
All
Target Recruitment
106
Inclusion Criteria

Age between 6 months and 14 years of old
Having lung wheezing on auscultation
Score > 4 based on the respiratory distress assessment scale

Exclusion Criteria

Having bronchopulmonary dysplasia
Having cystic fibrosis
Having congenital heart disease
Unwilling to participate in the study

Study & Design

Study Type
interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Assessment of respiratory distress. Timepoint: At the time of referral and at minutes 15, 30, 45 and 60. Method of measurement: Respiratory Distress Assessment Scale (RDAS).
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath